Financials
- Market Capitalization 459.46 M
- Employee 48
- Founded 2020
- CEO N/A
- Website www.evommune.com
- Headquarter Delaware, United States
- FIGI BBG00Y79N887
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
2.4
ratio cours/chiffre d'affaires
2.05
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2953 | EDIT Editas Medicine, Inc. - Common Stock | 3.06 USD | -3.16% | -0.33% | +18.60% | +21.43% | 469.95 M USD | ||
| 2959 | RLMD Relmada Therapeutics, Inc. - Common Stock | 4.36 USD | +0.69% | -5.83% | -17.11% | +285.84% | 465.08 M USD | ||
| 2972 | CCCC C4 Therapeutics, Inc. - Common Stock | 3.71 USD | -3.64% | -9.73% | +6.30% | +44.36% | 456.42 M USD | ||
| 2981 | RZLT Rezolute, Inc. - Common Stock | 4.69 USD | +1.52% | -5.06% | +3.30% | -34.13% | 451.61 M USD |